Laboratory Testing for Perimenopause
Perimenopause is primarily a clinical diagnosis based on menstrual history and age; routine laboratory testing is generally not necessary or recommended for diagnosis in women over 45 years with typical symptoms. 1
When to Order Labs
Women ≥45 Years with Typical Symptoms
- No laboratory testing needed 1, 2
- Diagnose based on:
- Menstrual irregularity (cycles >45 days apart or 3+ months amenorrhea)
- Vasomotor symptoms (hot flashes, night sweats)
- Age-appropriate presentation
Women 40-45 Years with Menopausal Symptoms
Order FSH levels to confirm early menopause 3
- Obtain during early follicular phase if cycles still present
- Repeat measurement after 4+ weeks if initial result borderline 4
- FSH >25 IU/L on two occasions supports diagnosis 4
Women <40 Years with Suspected Premature Ovarian Insufficiency
Comprehensive hormonal panel required 5, 4:
Essential tests:
- FSH (>25 IU/L on 2 measurements ≥4 weeks apart) 4
- Estradiol (<20 pg/mL indicates hypoestrogenism) 5
- LH (pattern interpretation with FSH) 5
- Prolactin (exclude hyperprolactinemia) 5
- TSH and free T4 (exclude thyroid dysfunction) 5
- β-hCG (exclude pregnancy) 5
Additional workup for POI:
- Anti-Müllerian hormone (AMH) - low/undetectable indicates diminished ovarian reserve 6, 5
- Total testosterone and DHEA-S if clinical hyperandrogenism present 5
- 8 AM 17-hydroxyprogesterone if late-onset congenital adrenal hyperplasia suspected 5
Women with Hysterectomy (No Uterus)
Laboratory confirmation helpful when clinical diagnosis unclear 1:
- FSH (replicate measures)
- Estradiol (<20 pg/mL suggests menopause)
- Interpret in context of vasomotor symptoms
Critical Pitfalls to Avoid
Single FSH measurements are unreliable due to cyclic fluctuations during perimenopause 2, 7. Women can have elevated FSH one month and normal levels the next while still perimenopausal.
Estradiol levels fluctuate wildly in perimenopause - a single normal value does not exclude the diagnosis 5. Estradiol can spike unpredictably even as ovarian function declines.
No single test rules in or out perimenopause 2. The combination of age, menstrual pattern, and symptoms provides better diagnostic accuracy than any laboratory value.
When Labs Add No Value
Do not order routine screening labs in typical perimenopausal women for diagnosis alone 1, 2. However, consider metabolic screening (lipids, glucose, HbA1c) as part of cardiovascular risk assessment if hormone therapy is being considered 8, 7, not for diagnosis.
Special Circumstances Requiring Additional Testing
If considering hormone therapy, obtain baseline:
- Lipid profile
- Fasting glucose or HbA1c
- Liver function tests (if risk factors present)
- These assess cardiovascular and metabolic risk, not menopausal status 7
If bone health concerns (prolonged amenorrhea ≥6 months):